Sulzer Medica Inter-Op Settlement Results In $546 Mil. Charge For Q2
This article was originally published in The Gray Sheet
Executive Summary
Nearly 70% of a $783 mil. proposed settlement for Sulzer Medica's Inter-Op hip recall and withdrawn tibial baseplates is being booked in the firm's second quarter, results for which were announced Sept. 19.